Liquidia Technologies (LQDA) Projected to Post Earnings on Wednesday

Key Points

• Liquidia Technologies is expected to report quarterly earnings on August 6th, with analysts predicting a loss of ($0.43) per share and revenue of $3.90 million.
• The company reported a net margin of -903.80% and a negative return on equity of -177.91% in the last quarter, with earnings missing expectations.
• Insider trading showed CEO Roger Jeffs selling shares, resulting in a 1.91% decrease in his position, while corporate insiders own 30.10% of the company's stock.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) is expected to release its Q2 2025 earnings data before the market opens on Wednesday, August 6th. Analysts expect Liquidia Technologies to post earnings of ($0.43) per share and revenue of $3.90 million for the quarter.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The firm had revenue of $3.12 million during the quarter, compared to analyst estimates of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. On average, analysts expect Liquidia Technologies to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Liquidia Technologies Price Performance

NASDAQ:LQDA traded down $1.01 on Friday, reaching $17.68. The stock had a trading volume of 3,309,216 shares, compared to its average volume of 2,570,489. The company has a market capitalization of $1.51 billion, a P/E ratio of -11.19 and a beta of 0.14. Liquidia Technologies has a 1-year low of $8.26 and a 1-year high of $20.33. The company has a quick ratio of 2.91, a current ratio of 2.93 and a debt-to-equity ratio of 2.08. The stock has a fifty day moving average price of $15.11 and a 200-day moving average price of $14.96.

Insider Activity at Liquidia Technologies

In other news, CEO Roger Jeffs sold 20,252 shares of the stock in a transaction on Monday, July 14th. The shares were sold at an average price of $14.28, for a total transaction of $289,198.56. Following the completion of the sale, the chief executive officer owned 1,038,560 shares of the company's stock, valued at $14,830,636.80. This represents a 1.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jason Adair sold 2,576 shares of the stock in a transaction on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $36,785.28. Following the sale, the insider directly owned 193,634 shares of the company's stock, valued at $2,765,093.52. This represents a 1.31% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 60,277 shares of company stock valued at $869,392 over the last three months. Insiders own 30.10% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Liquidia Technologies by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company's stock worth $556,000 after purchasing an additional 1,700 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Liquidia Technologies by 15.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company's stock worth $1,796,000 after purchasing an additional 16,022 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in Liquidia Technologies by 10.7% during the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company's stock worth $12,703,000 after purchasing an additional 82,955 shares during the last quarter. Institutional investors and hedge funds own 64.54% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Needham & Company LLC reaffirmed a "buy" rating on shares of Liquidia Technologies in a research note on Monday, June 2nd. Bank of America dropped their target price on shares of Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. Wells Fargo & Company boosted their target price on shares of Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a research note on Thursday, June 12th. HC Wainwright boosted their target price on shares of Liquidia Technologies from $29.00 to $35.00 and gave the stock a "buy" rating in a research note on Wednesday, May 28th. Finally, BTIG Research reaffirmed a "buy" rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $26.89.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).